Full
KCL-a

King’s College London
Institute of Psychiatry, King’s College London
Department of Neuroimaging
PO89 De Crespigny Park
London SE5 8AF,
United Kingdom

Project leader

Prof. Steven Williams
Phone:+44 (0) 203 228 3060
Fax:+44 (0) 203 228 2116

Project staff

Dr. David Lythgoe
Phone:+44 (0) 203 228 3069
Fax:+44 (0) 203 228 2116

 

Dr. Diana Cash
Phone:+44 (0) 207 848 0524
Fax:+44 (0) 203 228 2116

 

Institute presentation

The Department of Neuroimaging led by Professor Steve Williams is an academic Department embedded within the Centre for Neuroimaging Sciences (CNS). The CNS is a joint venture of the King's College London Institute of Psychiatry (IoP) and the South London and Maudsley NHS Trust (SLaM). 
The Centre promotes an interdisciplinary research environment with a world-leading combination of application-oriented brain imaging, analysis and clinical expertise for the definition, diagnosis and treatment of neurological and psychiatric disorders.
The Department of Neuroimaging also houses the Preclinical Imaging Unit (PIU), comprising state-of-the-art purpose built MR research facilities for preclinical experimental research and fully equipped to study a variety of disease models.

Research in the Department
 
Current research projects span neurodegeneration, epilepsy, stroke, pain, psychosis, affective disorders, developmental disorders and normal brain function, using a battery of neuroimaging techniques which include perfusion, diffusion, functional and structural imaging. Complementary research in imaging physics and analysis supports these applications.
Basic scientific research is also performed in models of neuropsychiatric disease, again using a diverse array of neuroimaging techniques, including pharmacological MRI and spectroscopy techniques. In conjunction with non-MR methods such as microscopy and autoradiography, this multifaceted approach enhances our understanding of the patho-physiological mechanisms underlying disease and informs the development of novel therapeutic interventions. In addition, improved understanding of the biological processes that underlie MR signal changes advances the crucial role of MR in non-invasive assessment of neuropsychiatric disease.
Our long-term objective is to translate our on-going pre-clinical developments in neuroimaging to the clinic, improving diagnosis and treatment of psychiatric and neurological diseases.


Top
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline